Liposomal Amphotericin B (AmBisome)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Liposomal Amphotericin B (AmBisome), covering 2012-09-24 to 2012-09-24. Get the full timeline:
Most recent: Clinical Trial Update: Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients [Phase 3]